FDA NDC Directory · JSON-LD · Markdown

Riastap

NDC 63833-892 · PLASMA DERIVATIVE · INJECTION, SOLUTION

Generic nameFIBRINOGEN HUMAN
Labeler / ManufacturerCSL Behring GmbH
Marketing categoryBiologic License Application · App BLA125317
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsFIBRINOGEN HUMAN (2600 mg/100mL)
Marketing started20090116
Package count1

External sources

Source: openFDA. Public-domain (CC0).